Alnylam Pharmaceuticals
ALNY
#1120
Rank
A$30.88 B
Marketcap
A$230.62
Share price
4.20%
Change (1 day)
-65.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company